Table 1.
Patient and Tumor Characteristics of Patients Included in This Study
| ACCs (n = 29) | ACAs (n = 16) | |
|---|---|---|
| Mean age at diagnosis, y | 53 (range 9–82) | 46 (range 26–61) |
| Mean follow-up, mo | 39 (range 3–187) | 34 (range 1–83) |
| Male, % | 11 (38%) | 3 (19%) |
| Mean tumor size, cm (SD) | 14.45 (SD 5.7) | 3.17 (SD 1.95) |
| Secretion | ||
| Androgens | 9 (31%) | 1 (6%) |
| Glucocorticoids | 15 (52%) | 6 (38%) |
| Mineralocorticoids | 0 (0%) | 5 (31%) |
| Precursors | 3 (10%) | 0 (0%) |
| Estradiol | 4 (14%) | 0 (0%) |
| Nonsecreting | 12 (41%) | 4 (25%) |
| Weiss score (SD) | 6.0 (SD 1.31) | 0.25 (SD 0.45) |
| Van Slooten Index | 21.1 (SD 4.8) (n = 26) | 1.56 (SD 0.869) |
| ENSAT | ||
| I | 0 (0%) | 14 (88%) |
| II | 15 (52%) | 2 (13%) |
| III | 3 (10%) | 0 (0%) |
| IV | 11 (37%) | 0 (0%) |
Van Slooten Index was not available for all patients, dependent on the year of diagnosis.